Evidence map›Paper›PMID 27906075›Full record

ArticleSkeletal muscle2016

Nuclear bodies reorganize during myogenesis in vitro and are differentially disrupted by expression of FSHD-associated DUX4.

Sachiko Homma, Mary Lou Beermann, Bryant Yu, Frederick M Boyce, Jeffrey Boone Miller

Open access · goldAbstract read
In one paragraph

Article in Skeletal muscle, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The metabolic enzyme GYS1 condenses with NONO/p54Cell death and differentiation · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Molecular and Phenotypic Changes in FLExDUX4 Mice.Journal of personalized medicine · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sachiko HommaDepartment of Neurology, Boston University School of Medicine, Boston, MA, 02118, USA.
Mary Lou BeermannDepartment of Neurology, Boston University School of Medicine, Boston, MA, 02118, USA.
Bryant YuDepartment of Neurology, Boston University School of Medicine, Boston, MA, 02118, USA.
Frederick M BoyceDepartment of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Jeffrey Boone MillerDepartment of Neurology, Boston University School of Medicine, Boston, MA, 02118, USA. millerjb@bu.edu.
Boston University · USMassachusetts General Hospital · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Mechanisms of DUX4 mediated FSHD pathologyR01AR062587 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JONES, PETER L · 2013 to 2024
$5.3M
Pathogenesis of Muscular DystrophiesR01AR060328 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MILLER, JEFFREY BOONE · 2012 to 2016
$2.5M
NCATS NIH HHS UL1 TR001430NIAMS NIH HHS R01 AR060328NIAMS NIH HHS R01 AR062587
6 · The paper itself

Abstract

backgroundNuclear bodies, such as nucleoli, PML bodies, and SC35 speckles, are dynamic sub-nuclear structures that regulate multiple genetic and epigenetic processes. Additional regulation is provided by RNA/DNA handling proteins, notably TDP-43 and FUS, which have been linked to ALS pathology. Previous work showed that mouse cell line myotubes have fewer but larger nucleoli than myoblasts, and we had found that nuclear aggregation of TDP-43 in human myotubes was induced by expression of DUX4-FL, a transcription factor that is aberrantly expressed and causes pathology in facioscapulohumeral dystrophy (FSHD). However, questions remained about nuclear bodies in human myogenesis and in muscle disease.

methodsWe examined nucleoli, PML bodies, SC35 speckles, TDP-43, and FUS in myoblasts and myotubes derived from healthy donors and from patients with FSHD, laminin-alpha-2-deficiency (MDC1A), and alpha-sarcoglycan-deficiency (LGMD2D). We further examined how these nuclear bodies and proteins were affected by DUX4-FL expression.

resultsWe found that nucleoli, PML bodies, and SC35 speckles reorganized during differentiation in vitro, with all three becoming less abundant in myotube vs. myoblast nuclei. In addition, though PML bodies did not change in size, both nucleoli and SC35 speckles were larger in myotube than myoblast nuclei. Similar patterns of nuclear body reorganization occurred in healthy control, MDC1A, and LGMD2D cultures, as well as in the large fraction of nuclei that did not show DUX4-FL expression in FSHD cultures. In contrast, nuclei that expressed endogenous or exogenous DUX4-FL, though retaining normal nucleoli, showed disrupted morphology of some PML bodies and most SC35 speckles and also co-aggregation of FUS with TDP-43.

conclusionsNucleoli, PML bodies, and SC35 speckles reorganize during human myotube formation in vitro. These nuclear body reorganizations are likely needed to carry out the distinct gene transcription and splicing patterns that are induced upon myotube formation. DUX4-FL-induced disruption of some PML bodies and most SC35 speckles, along with co-aggregation of TDP-43 and FUS, could contribute to pathogenesis in FSHD, perhaps by locally interfering with genetic and epigenetic regulation of gene expression in the small subset of nuclei that express high levels of DUX4-FL at any one time.

Indexed as

Muscle DevelopmentAdaptor Proteins, Signal TransducingCell Cycle ProteinsCell NucleolusCells, CulturedDNA-Binding ProteinsEpigenesis, GeneticHomeodomain ProteinsHumansIntranuclear Inclusion BodiesMuscle Fibers, SkeletalMuscular Dystrophy, FacioscapulohumeralNuclear ProteinsTrans-ActivatorsAdaptor Proteins, Signal TransducingCell Cycle ProteinsDNA-Binding ProteinsDUX4L1 protein, humanHomeodomain ProteinsMDC1 protein, humanNuclear ProteinsTARDBP protein, humanTrans-ActivatorsDUX4Facioscapulohumeral muscular dystrophyFUSMyotubeNucleoliPML bodiesSC35 specklesTDP-43

Identifiers

PMID27906075
PMCPMC5134237
OpenAlexW2558831540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.